Several recent studies have indicated the prognostic and predictive value of measuring concentrations of NfL in the peripheral blood in chronic neurological diseases including amyotrophic lateral sclerosis (ALS)38, multiple sclerosis (MS)39, AD40, Parkinson’s Disease (PD)13, as well as peripheral neuropathies41. The gene discussed is NEFL; the disease is multiple sclerosis.